6-134028459-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_145176.3(SLC2A12):c.1366G>A(p.Val456Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,058 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145176.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A12 | NM_145176.3 | c.1366G>A | p.Val456Ile | missense_variant | 2/5 | ENST00000275230.6 | NP_660159.1 | |
SLC2A12 | XM_006715349.5 | c.1366G>A | p.Val456Ile | missense_variant | 2/3 | XP_006715412.1 | ||
SLC2A12 | XM_017010311.3 | c.1366G>A | p.Val456Ile | missense_variant | 2/3 | XP_016865800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A12 | ENST00000275230.6 | c.1366G>A | p.Val456Ile | missense_variant | 2/5 | 1 | NM_145176.3 | ENSP00000275230.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251276Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135786
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461856Hom.: 2 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727226
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.1366G>A (p.V456I) alteration is located in exon 2 (coding exon 2) of the SLC2A12 gene. This alteration results from a G to A substitution at nucleotide position 1366, causing the valine (V) at amino acid position 456 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at